Ziegler Capital Management’s Coherus Oncology CHRS Stock Holding History

Ziegler Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-39,737	Closed	-$513K	–	391
2022 Q1	$513K	Hold	39,737	–	–	0.02%	333
2021 Q4	$634K	Sell	39,737 -14,082	-26%	-$246K	0.02%	356
2021 Q3	$865K	Sell	53,819 -1,955	-4%	-$28.7K	0.03%	346
2021 Q2	$771K	Sell	55,774 -1,795	-3%	-$25.4K	0.03%	355
2021 Q1	$841K	Buy	57,569 +28,616	+99%	+$486K	0.03%	347
2020 Q4	$503K	Sell	28,953 -3,384	-10%	-$60.2K	0.02%	382
2020 Q3	$593K	Sell	32,337 -30,140	-48%	-$561K	0.02%	360
2020 Q2	$1.12M	Buy	+62,477	New	+$1.06M	0.04%	288

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ziegler Capital Management's CHRS Position: Q2 2022 in Review

Ziegler Capital Management sold out of Coherus Oncology (CHRS) in Q2 2022, closing a stake of 39,737 shares — an estimated $513K sold.

Ziegler Capital Management first reported a position in CHRS in Q2 2020 and held it in 8 quarters. The position peaked at $1.12M in Q2 2020. 176 funds tracked by Wall St. Rank hold CHRS as of Q2 2022.

Ziegler Capital Management reported no remaining Coherus Oncology position as of Q2 2022 after selling out during the quarter.
Ziegler Capital Management sold 39,737 Coherus Oncology shares in Q2 2022, an estimated $513K.
Ziegler Capital Management first reported a position in Coherus Oncology in Q2 2020 and held it in 8 quarters.
Ziegler Capital Management's Coherus Oncology position peaked at $1.12M in Q2 2020.
176 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2022.

Based on Ziegler Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.